Jane Street’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,612
Closed -$30.8K 10154
2024
Q2
$30.8K Buy
+1,612
New +$31.4K ﹤0.01% 9003
2023
Q1
Sell
-1,979
Closed -$33.5K 9658
2022
Q4
$33.5K Buy
+1,979
New +$45.5K ﹤0.01% 8475
2022
Q2
Sell
-1,255
Closed -$73K 10493
2022
Q1
$73K Buy
+1,255
New +$78.5K ﹤0.01% 9565
2021
Q3
Sell
-1,260
Closed -$121K 10491
2021
Q2
$121K Buy
+1,260
New +$129K ﹤0.01% 9172
2020
Q3
Sell
-939
Closed -$242K 7679
2020
Q2
$242K Buy
+939
New +$358K ﹤0.01% 6138

Other funds holding NXTC

Jane Street's NXTC Position: Q3 2024 in Review

Jane Street sold out of NextCure (NXTC) in Q3 2024, closing a stake of 1,612 shares — an estimated $30.8K sold.

Jane Street first reported a position in NXTC in Q2 2020 and held it in 5 quarters. The position peaked at $242K in Q2 2020. 43 funds tracked by Wall St. Rank hold NXTC as of Q3 2024.

  • Jane Street reported no remaining NextCure position as of Q3 2024 after selling out during the quarter.
  • Jane Street sold 1,612 NextCure shares in Q3 2024, an estimated $30.8K.
  • Jane Street first reported a position in NextCure in Q2 2020 and held it in 5 quarters.
  • Jane Street's NextCure position peaked at $242K in Q2 2020.
  • 43 funds tracked by Wall St. Rank held NextCure as of Q3 2024.

Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.